Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Management Case Studies - Session B
Track:
Sessions
Program Code: 313-L04
Date: Tuesday, December 5, 2006
Time: 2:00 PM to 4:30 PM
Location:
207A-B (CC)
MODERATOR:
Alan Hopefl, Pharm.D., Senior Clinical Manager, Amerinet, St. Louis, MO
SPEAKER(S):
Leroy G. Candelaria, President, Biotech Pharmacy, Inc., El Paso, TX
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Lisa M. Chastain, Pharmacy Resident, Texas Tech University Health Sciences Center School of Pharmacy, Dallas
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Robyn DeFife
C. Kevin Early, Informatics Analyst, Hospital of Saint Raphael, New Haven, CT
Process Improvement Using Clinical Decision Support for High-Risk Medications Based on Medication Variance Reporting (MCS-7)
Joslyn Emerson, Pharmacist, Northwestern Memorial Hospital, Chicago, IL
Safety of Intravenous Medications and Infusion Pumps in Labor and Delivery (MCS-9)
Milo Knight, Director, Sales/Marketing, Biotech Pharmacy, Inc., El Paso, TX
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Janet M. Kozakiewicz, Director of Pharmacy Services, Hospital of Saint Raphael, New Haven, CT
Process Improvement Using Clinical Decision Support for High-Risk Medications Based on Medication Variance Reporting (MCS-7)
Kathleen A. Moorman, Pharmacy Director, University Community Hospital, Tampa, FL
Improving Patient Safety by Developing a User-Friendly Label That Complies with USP <797> and NPSG 3D (MCS-6)
Roland A. Patry, Professor and Chair, Clinical Practice Management, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Maria C. Perez, Pharmacy Manager, University Community Hospital-Carrollwood, Tampa, FL
Improving Patient Safety by Developing a User-Friendly Label That Complies with USP <797> and NPSG 3D (MCS-6)
Michael Pinġn, Clinical Coordinator, Sierra Medical Center, El Paso, TX
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Teresa H. Seo, Assistant Director, Clinical Services, Hospital of Saint Raphael, New Haven, CT
Process Improvement Using Clinical Decision Support for High-Risk Medications Based on Medication Variance Reporting (MCS-7)
Linda S. Tyler, Pharm.D., FASHP, Director, Drug Information Service, University of Utah Hospitals & Clinics, Department of Pharmacotherapy; University of Utah College of Pharmacy
Anticoagulant Failure Mode Effects Analysis (FMEA): Applying Statewide Project to Our Organization to Improve Care (MCS-10)
Maumi C. Villarreal, Director, Quality Improvement, Biotech Pharmacy, Inc., El Paso, TX
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Michelle Wheeler, Anticoagulation Specialist, University of Utah Hospitals and Clinics, Salt Lake City
Anticoagulant Failure Mode Effects Analysis (FMEA): Applying Statewide Project to Our Organization to Improve Care (MCS-10)
Brett Whittacre, President, Diodose L.L.C., Las Vegas, NV
Prospective Pharmacy Monitoring of Radiological Medications in a 325-Bed, Acute Care Hospital: Meeting Joint Commission?s Standards for Improved Patient Safety (MCS-8)
Robbie C. Williams, Surgery Nurse Leader, University Community Hospital, Tampa, FL
Improving Patient Safety by Developing a User-Friendly Label That Complies with USP <797> and NPSG 3D (MCS-6)
Jennifer Zook